US OptionsDetailed Quotes
RIGL241220P1000
- 0.30
- 0.000.00%
15min DelayClose Jun 25 12:47 ET
0.00High0.00Low
0.00Open0.30Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover2309.39%IV96.34%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.0075Delta0.0005Gamma63.80Leverage Ratio-0.1291Theta0.0000Rho-0.48Eff Leverage0.0004Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet